Top

Published in:

01-12-2020 | Central Nervous System Trauma | Original Paper

miR-146a Mimics Ameliorates Traumatic Brain Injury Involving JNK and NF-κB Signaling Pathway

Authors: Lei Zhang, Li Zhao, Wei Zhu, Yuexia Ding, Hongguang Chen, Nan Chi

Published in: NeuroMolecular Medicine | Issue 4/2020

Abstract

Traumatic brain injury (TBI) is one of the leading causes of morbidity and mortality among the world, while the advance of TBI management is rather limited in recent years. The deregulation of microRNAs (miRNAs) has been widely reported in TBI patients and animal models, and certain miRNAs have been identified as the emerging biomarkers of TBI. However, the role of miRNAs in the regulatory mechanism of TBI remains unclear. To demonstrate the effect of miR-146a mimic on TBI-induced neural damages, TBI mouse model was constructed by cortical impact injury (CCI). The chemokine levels were examined by ELISA assays. Behavioral experiments were used to estimate the impact of miR-146a mimics on neurological functions in mice. Western blot assays were performed to demonstrate the protein levels. qRT-PCR assays were utilized to investigate the expression alteration of RNA levels. It was found that miR-146a was upregulated both in brain and serum in TBI mice. miR-146a mimic downregulated inflammatory cytokines secretion in mouse brain. The NF-κB signaling pathway was inhibited by miR-146a mimic. miR-146a treatment attenuated the impact caused by TBI to mouse brain and improve the long-term neurological function. In conclusion, miR-146a mimics ameliorate TBI-related injuries via JNK and NF-κB signaling pathway.

Atif, H., & Hicks, S. D. (2019). A review of microRNA biomarkers in traumatic brain injury. Journal of Experimental Neuroscience, 13, 1179069519832286. https://doi.org/10.1177/1179069519832286.CrossRefPubMedPubMedCentral

Barry, G. (2014). Integrating the roles of long and small non-coding RNA in brain function and disease. Molecular Psychiatry, 19(4), 410–416. https://doi.org/10.1038/mp.2013.196.CrossRefPubMed

Bhomia, M., Balakathiresan, N. S., Wang, K. K., Papa, L., & Maheshwari, R. K. (2016). A panel of serum miRNA biomarkers for the diagnosis of severe to mild traumatic brain injury in humans. Scientific Reports, 6, 28148. https://doi.org/10.1038/srep28148.CrossRefPubMedPubMedCentral

Bhowmick, S., D'Mello, V., Caruso, D., & Abdul-Muneer, P. M. (2019). Traumatic brain injury-induced downregulation of Nrf2 activates inflammatory response and apoptotic cell death. Journal of Molecular Medicine, 97(12), 1627–1641. https://doi.org/10.1007/s00109-019-01851-4.CrossRefPubMed

Brazinova, A., Rehorcikova, V., Taylor, M. S., Buckova, V., Majdan, M., Psota, M., et al. (2018). Epidemiology of traumatic brain injury in Europe: A living systematic review. Journal of Neurotrauma. https://doi.org/10.1089/neu.2015.4126.CrossRefPubMed

Bruns, J., Jr., & Hauser, W. A. (2003). The epidemiology of traumatic brain injury: A review. Epilepsia, 44(s10), 2–10. https://doi.org/10.1046/j.1528-1157.44.s10.3.x.CrossRefPubMed

Chang, V. C., Guerriero, E. N., & Colantonio, A. (2015). Epidemiology of work-related traumatic brain injury: A systematic review. American Journal of Industrial Medicine, 58(4), 353–377. https://doi.org/10.1002/ajim.22418.CrossRefPubMed

Danborg, P. B., Simonsen, A. H., Waldemar, G., & Heegaard, N. H. (2014). The potential of microRNAs as biofluid markers of neurodegenerative diseases—A systematic review. Biomarkers, 19(4), 259–268. https://doi.org/10.3109/1354750X.2014.904001.CrossRefPubMed

DeKosky, S. T., & Asken, B. M. (2017). Injury cascades in TBI-related neurodegeneration. Brain Injury, 31(9), 1177–1182. https://doi.org/10.1080/02699052.2017.1312528.CrossRefPubMedPubMedCentral

Dewan, M. C., Mummareddy, N., Wellons, J. C., 3rd, & Bonfield, C. M. (2016). Epidemiology of global pediatric traumatic brain injury: Qualitative review. World Neurosurgery, 91(497–509), e491. https://doi.org/10.1016/j.wneu.2016.03.045.CrossRef

Dinet, V., Petry, K. G., & Badaut, J. (2019). Brain-immune interactions and neuroinflammation after traumatic brain injury. Frontiers in Neuroscience, 13, 1178. https://doi.org/10.3389/fnins.2019.01178.CrossRefPubMedPubMedCentral

Ferreira, A. P., Rodrigues, F. S., Della-Pace, I. D., Mota, B. C., Oliveira, S. M., Velho Gewehr, C., et al. (2013). The effect of NADPH-oxidase inhibitor apocynin on cognitive impairment induced by moderate lateral fluid percussion injury: Role of inflammatory and oxidative brain damage. Neurochemistry International, 63(6), 583–593. https://doi.org/10.1016/j.neuint.2013.09.012.CrossRefPubMed

Ginhoux, F., Lim, S., Hoeffel, G., Low, D., & Huber, T. (2013). Origin and differentiation of microglia. Frontiers in Cellular Neuroscience, 7, 45. https://doi.org/10.3389/fncel.2013.00045.CrossRefPubMedPubMedCentral

Harrison, E. B., Hochfelder, C. G., Lamberty, B. G., Meays, B. M., Morsey, B. M., Kelso, M. L., et al. (2016). Traumatic brain injury increases levels of miR-21 in extracellular vesicles: Implications for neuroinflammation. FEBS Open Bio, 6(8), 835–846. https://doi.org/10.1002/2211-5463.12092.CrossRefPubMedPubMedCentral

Hicks, S. D., Johnson, J., Carney, M. C., Bramley, H., Olympia, R. P., Loeffert, A. C., et al. (2018). Overlapping microRNA expression in saliva and cerebrospinal fluid accurately identifies pediatric traumatic brain injury. Journal of Neurotrauma, 35(1), 64–72. https://doi.org/10.1089/neu.2017.5111.CrossRefPubMedPubMedCentral

Jassam, Y. N., Izzy, S., Whalen, M., McGavern, D. B., & El Khoury, J. (2017). Neuroimmunology of traumatic brain injury: Time for a paradigm shift. Neuron, 95(6), 1246–1265. https://doi.org/10.1016/j.neuron.2017.07.010.CrossRefPubMedPubMedCentral

Johnson, J. J., Loeffert, A. C., Stokes, J., Olympia, R. P., Bramley, H., & Hicks, S. D. (2018). Association of salivary microRNA changes with prolonged concussion symptoms. JAMA Pediatrics, 172(1), 65–73. https://doi.org/10.1001/jamapediatrics.2017.3884.CrossRefPubMed

Kokiko-Cochran, O., Ransohoff, L., Veenstra, M., Lee, S., Saber, M., Sikora, M., et al. (2016). Altered neuroinflammation and behavior after traumatic brain injury in a mouse model of Alzheimer's disease. Journal of Neurotrauma, 33(7), 625–640. https://doi.org/10.1089/neu.2015.3970.CrossRefPubMedPubMedCentral

Lasry, O., Liu, E. Y., Powell, G. A., Ruel-Laliberte, J., Marcoux, J., & Buckeridge, D. L. (2017). Epidemiology of recurrent traumatic brain injury in the general population: A systematic review. Neurology, 89(21), 2198–2209. https://doi.org/10.1212/WNL.0000000000004671.CrossRefPubMedPubMedCentral

Lozano, D., Gonzales-Portillo, G. S., Acosta, S., de la Pena, I., Tajiri, N., Kaneko, Y., et al. (2015). Neuroinflammatory responses to traumatic brain injury: Etiology, clinical consequences, and therapeutic opportunities. Neuropsychiatric Disease and Treatment, 11, 97–106. https://doi.org/10.2147/NDT.S65815.CrossRefPubMedPubMedCentral

Masson, F., Thicoipe, M., Aye, P., Mokni, T., Senjean, P., Schmitt, V., et al. (2001). Epidemiology of severe brain injuries: A prospective population-based study. Journal of Trauma, 51(3), 481–489. https://doi.org/10.1097/00005373-200109000-00010.CrossRefPubMed

Miao, W., Bao, T. H., Han, J. H., Yin, M., Yan, Y., Wang, W. W., et al. (2015). Voluntary exercise prior to traumatic brain injury alters miRNA expression in the injured mouse cerebral cortex. Brazilian Journal of Medical and Biological Research, 48(5), 433–439. https://doi.org/10.1590/1414-431X20144012.CrossRefPubMedPubMedCentral

Ng, S. Y., & Lee, A. Y. W. (2019). Traumatic brain injuries: Pathophysiology and potential therapeutic targets. Frontiers in Cellular Neuroscience, 13, 528. https://doi.org/10.3389/fncel.2019.00528.CrossRefPubMedPubMedCentral

Pan, Y. B., Sun, Z. L., & Feng, D. F. (2017). The role of microRNA in traumatic brain injury. Neuroscience, 367, 189–199. https://doi.org/10.1016/j.neuroscience.2017.10.046.CrossRefPubMed

Paterson, M. R., & Kriegel, A. J. (2017). miR-146a/b: A family with shared seeds and different roots. Physiological Genomics, 49(4), 243–252. https://doi.org/10.1152/physiolgenomics.00133.2016.CrossRefPubMedPubMedCentral

Pellegrini, K. L., Gerlach, C. V., Craciun, F. L., Ramachandran, K., Bijol, V., Kissick, H. T., et al. (2016). Application of small RNA sequencing to identify microRNAs in acute kidney injury and fibrosis. Toxicology and Applied Pharmacology, 312, 42–52. https://doi.org/10.1016/j.taap.2015.12.002.CrossRefPubMed

Pereira, P., Queiroz, J. A., Figueiras, A., & Sousa, F. (2017). Current progress on microRNAs-based therapeutics in neurodegenerative diseases. Wiley Interdisciplinary Reviews: RNA. https://doi.org/10.1002/wrna.1409.CrossRefPubMed

Quinlan, S., Kenny, A., Medina, M., Engel, T., & Jimenez-Mateos, E. M. (2017). microRNAs in neurodegenerative diseases. International Review of Cell and Molecular Biology, 334, 309–343. https://doi.org/10.1016/bs.ircmb.2017.04.002.CrossRefPubMed

Ramlackhansingh, A. F., Brooks, D. J., Greenwood, R. J., Bose, S. K., Turkheimer, F. E., Kinnunen, K. M., et al. (2011). Inflammation after trauma: Microglial activation and traumatic brain injury. Annals of Neurology, 70(3), 374–383. https://doi.org/10.1002/ana.22455.CrossRefPubMed

Redell, J. B., Liu, Y., & Dash, P. K. (2009). Traumatic brain injury alters expression of hippocampal microRNAs: Potential regulators of multiple pathophysiological processes. Journal of Neuroscience Research, 87(6), 1435–1448. https://doi.org/10.1002/jnr.21945.CrossRefPubMedPubMedCentral

Redell, J. B., Moore, A. N., Ward, N. H., 3rd, Hergenroeder, G. W., & Dash, P. K. (2010). Human traumatic brain injury alters plasma microRNA levels. Journal of Neurotrauma, 27(12), 2147–2156. https://doi.org/10.1089/neu.2010.1481.CrossRefPubMedPubMedCentral

Schwulst, S. J., Trahanas, D. M., Saber, R., & Perlman, H. (2013). Traumatic brain injury-induced alterations in peripheral immunity. The Journal of Trauma and Acute Care Surgery, 75(5), 780–788. https://doi.org/10.1097/TA.0b013e318299616a.CrossRefPubMedPubMedCentral

Shah, S. Z. A., Zhao, D., Hussain, T., Sabir, N., & Yang, L. (2018). Regulation of microRNAs-mediated autophagic flux: A new regulatory avenue for neurodegenerative diseases with focus on prion diseases. Frontiers in Aging Neuroscience, 10, 139. https://doi.org/10.3389/fnagi.2018.00139.CrossRefPubMedPubMedCentral

Sheinerman, K. S., Toledo, J. B., Tsivinsky, V. G., Irwin, D., Grossman, M., Weintraub, D., et al. (2017). Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases. Alzheimer's Research & Therapy, 9(1), 89. https://doi.org/10.1186/s13195-017-0316-0.CrossRef

Sun, P., Liu, D. Z., Jickling, G. C., Sharp, F. R., & Yin, K. J. (2018). microRNA-based therapeutics in central nervous system injuries. Journal of Cerebral Blood Flow and Metabolism, 38(7), 1125–1148. https://doi.org/10.1177/0271678X18773871.CrossRefPubMedPubMedCentral

Taganov, K. D., Boldin, M. P., Chang, K. J., & Baltimore, D. (2006). NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences of the United States of America, 103(33), 12481–12486. https://doi.org/10.1073/pnas.0605298103.CrossRefPubMedPubMedCentral

Tao, L., Li, D., Liu, H., Jiang, F., Xu, Y., Cao, Y., et al. (2018). Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-kappaB and MAPK signaling pathway. Brain Research Bulletin, 140, 154–161. https://doi.org/10.1016/j.brainresbull.2018.04.008.CrossRefPubMed

Theus, M. H., Brickler, T., Meza, A. L., Coutermarsh-Ott, S., Hazy, A., Gris, D., et al. (2017). Loss of NLRX1 exacerbates neural tissue damage and NF-kappa B signaling following brain injury. The Journal of Immunology, 199(10), 3547–3558. https://doi.org/10.4049/jimmunol.1700251.CrossRefPubMed

Thurman, D. J. (2016). The epidemiology of traumatic brain injury in children and youths: A review of research since 1990. Journal of Child Neurology, 31(1), 20–27. https://doi.org/10.1177/0883073814544363.CrossRefPubMed

Xiong, Y., Mahmood, A., & Chopp, M. (2018). Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities. Chinese Journal of Traumatology, 21(3), 137–151. https://doi.org/10.1016/j.cjtee.2018.02.003.CrossRefPubMedPubMedCentral

Zhu, W., Zhao, L., Li, T., Xu, H., Ding, Y., & Cui, G. (2019). Docosahexaenoic acid ameliorates traumatic brain injury involving JNK-mediated Tau phosphorylation signaling. Neuroscience Research. https://doi.org/10.1016/j.neures.2019.07.008.CrossRefPubMed

Title: miR-146a Mimics Ameliorates Traumatic Brain Injury Involving JNK and NF-κB Signaling Pathway
Authors: Lei Zhang
Li Zhao
Wei Zhu
Yuexia Ding
Hongguang Chen
Nan Chi
Publication date: 01-12-2020
Publisher: Springer US
Keyword: Central Nervous System Trauma
Published in: NeuroMolecular Medicine / Issue 4/2020
Print ISSN: 1535-1084
Electronic ISSN: 1559-1174
DOI: https://doi.org/10.1007/s12017-020-08599-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

miR-146a Mimics Ameliorates Traumatic Brain Injury Involving JNK and NF-κB Signaling Pathway

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2020

Cell-Free Extracellular Vesicles Derived from Human Bone Marrow Endothelial Progenitor Cells as Potential Therapeutics for Microvascular Endothelium Restoration in ALS

Transcriptomic Heterogeneity of Alzheimer’s Disease Associated with Lipid Genetic Risk

CD137 Ligand-CD137 Interaction is Required For Inflammasome-Associated Brain Injury Following Ischemic Stroke

Oxytocin Reduces Brain Injury and Maintains Blood–Brain Barrier Integrity After Ischemic Stroke in Mice

HLA in Alzheimer’s Disease: Genetic Association and Possible Pathogenic Roles

Galuteolin Inhibited Autophagy for Neuroprotection Against Transient Focal Cerebral Ischemia in Rats